ACCELER8 CLINICAL RESEARCH (ASIA) PTE. LTD. (201614966C)

ACCELER8 CLINICAL RESEARCH (ASIA) PTE. LTD. is a Sole Proprietorship/ Partnership registered in Singapore under the Unique Entity Number (UEN) 201614966C. The company operates as a Private Company Limited by Shares and is currently listed as a Live Company.

Company Overview

ACCELER8 CLINICAL RESEARCH (ASIA) PTE. LTD. was incorporated on June, 02 2016 and is regulated by the ACRA. The UEN was officially issued on June, 02 2016.

• Company Name: ACCELER8 CLINICAL RESEARCH (ASIA) PTE. LTD.
• Unique Entity Number (UEN): 201614966C
• Issuance Agency: ACRA
• Entity Type: Local Company
• Company Type: Private Company Limited by Shares
• Company Status: Live Company
• Number of Officers: 9

Registered Business Address

The registered business address of ACCELER8 CLINICAL RESEARCH (ASIA) PTE. LTD. is classified as a LOCAL address and is located at:

Business Classification & Activities

ACCELER8 CLINICAL RESEARCH (ASIA) PTE. LTD. is registered under the Singapore Standard Industrial Classification (SSIC) code 72106 - Research and experimental development on medical and veterinary sciences.

Former Company Names

The company has previously operated under the following registered names:

• THE CLINICAL TRIAL COMPANY (ASIA)

Statutory & Compliance Information

• Account Due Date: October, 31 2026
• Annual Return Filing Date: September, 29 2025

Audit & Governance

Based on publicly available records, no audit firm information has been disclosed.

Additional Corporate Information

• Business Constitution: N/A
• PAF Constitution: N/A